In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents

被引：194
|
作者：
Almyroudis, Nikolaos G.
Sutton, Deanna A.
Fothergill, Annette W.
Rinaldi, Michael G.
Kusne, Shimon
机构：
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY USA
[2] Dept Pathol, Fungus Testing Lab, San Antonio, TX USA
[3] Audie L Murphy Mem Vet Adm Med Ctr, S Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Mayo Clin, Phoenix, AZ USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 07期
关键词：
D O I：
10.1128/AAC.00452-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with Cunninghamella bertholletiae.
引用
收藏
页码：2587 / 2590
页数：4
相关论文
共 50 条
  • [1] In vitro susceptibilities of zygomycetes to conventional and new antifungals
    Dannaoui, E
    Meletiadis, J
    Mouton, JW
    Meis, JFGM
    Verweij, PE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 45 - 52
  • [2] In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates
    Meletiadis, J
    Meis, JFGM
    Mouton, JW
    Rodriquez-Tudela, JL
    Donnelly, JP
    Verweij, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 62 - 68
  • [3] In vitro antifungal susceptibilities of Ugandan clinical isolates
    Smith, K.
    Achan, B.
    McDonald, T.
    Akampurira, A.
    Okagaki, L.
    Meya, D.
    Boulware, D. R.
    Nielsen, K.
    [J]. MYCOSES, 2014, 57 : 43 - 44
  • [4] In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole
    Torres-Rodríguez, JM
    Mendez, R
    López-Jodra, O
    Morera, Y
    Espasa, M
    Jimenez, T
    Lagunas, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1258 - 1259
  • [5] In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents
    Dannaoui, E
    Afeltra, J
    Meis, JFGM
    Verweij, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2708 - 2711
  • [6] In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
    Pfaller, MA
    Messer, SA
    Coffman, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) : 763 - 766
  • [7] Molecular characterization and in vitro antifungal susceptibilities of 75 clinical Zygomycetes isolated in Delhi, India
    Kathuria, S.
    Klaassen, C. H.
    Roy, P.
    Najafzadeh, M. J.
    de Hoog, G. S.
    Meis, J. F.
    Randhawa, H. S.
    Chowdhary, A.
    [J]. MYCOSES, 2012, 55 : 108 - 108
  • [8] IN-VITRO SUSCEPTIBILITIES OF CLINICAL YEAST ISOLATES TO 3 ANTIFUNGAL AGENTS DETERMINED BY THE MICRODILUTION METHOD
    PFALLER, MA
    BARRY, AL
    [J]. MYCOPATHOLOGIA, 1995, 130 (01) : 3 - 9
  • [9] In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey
    Yenisehirli, Gulgun
    Bulut, Nermin
    Yenisehirli, Aydan
    Bulut, Yunus
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (09)
  • [10] In vitro antifungal susceptibilities of Scopulariopsis isolates
    Aguilar, C
    Pujol, I
    Guarro, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1520 - 1522
12345